Table 2.

Selection of Postmortem Gene Expression Studies

Citation	Sample	Brain Regions	Gene Expression Method
Nakata et al., 2009	61 SCZ, 30 CON	Hippocampus	RT-qPCR
	29W, 62NW
Kim et al., 2010	35 SCZ, 35 BPD, 33 CON	DLPFC (BA46)	RT-qPCR (miRNA)
	102W, 1NW
Choi et al., 2011	40 BPD, 43 CON	PFC (BA46)	Microarray
	83W
Ramaker et al., 2017	24 SCZ, 24 BPD, 24 MDD, 24 CON	ACC, DLPFC (BA46), NAc	RNA-seq
	89W, 7NW
Darby et al., 2016	35 SCZ, 33 BPD, 32 CON	Hippocampus	RNA-seq
	98W, 2 NW
Pandey et al., 2018	31 SCZ, 24 CON	PFC (BA9)	RT-qPCR
	38W, 17NW
Pantazatos et al., 2017	30 MDD, 29 CON	PFC (BA9)	RNA-seq
	59 W
Hwang et al., 2013	14 SCZ, 15 CON	Hippocampus	RNA-seq
	29W
Schmitt et al., 2010	10 SCZ, 9 CON	Cerebellum	RT-qPCR
	19W
Fromer et al., 2016	258 SCZ, 279 CON	DLPFC (BA46, BA9)	RNA-seq
	433W, 104NW
Williamson et al., 2015	27 SCZ, 29 BPD, 22 CON	DLPFC (BA46)	RT-qPCR (miRNA)
	77W, 1NW
Kim et al., 2010	10 BPD, 10 CON	PFC (BA9)	RT-qPCR
	20W
Li et al., 2013	34 MDD, 55 CON	DLPFC, ACC, NAc, HIPP, CB, AMYG	Microarray
	89W
Kaalund et al., 2014	176 SCZ, 61 BPD, 138 MDD, 326 CON	DLPFC, HIPP, Caudate nucleus	RT-qPCR
	403W, 296NW
Gray et al., 2015	53 MDD, 32 CON	DLPFC	RT-qPCR
	58W, 27NW

Postmortem gene expression studies with information about sample sizes and demographics, brain regions investigated, and method for gene expression quantification.

SCZ= schizophrenia, BPD= bipolar disorder, MDD= major depressive disorder CON= control

W= White, NW= non-white